Investor Presentaiton
Governance
A World-Class Board of Directors
The majority of members of IDH's Board of Directors are independent and offer
significant experience in the healthcare market, MENA region and investment activities
Lord St John of Bletso 1
Independent Non-Executive
Prof. Dr. Hend El Sherbini
Group Chief Executive Officer
Hussein Choucri 1,2,3,4
Independent Non-Executive
Director and Chairman of the
Remuneration Committee
Lord St John has been a crossbencher in the House of Lords, UK
Parliament, since 1978 and is an Extra Lord-in-Waiting to HM Queen
Elizabeth II. He is currently non-executive chairman of Strand Hanson
Ltd and Global Resources Investment Trust (GRIT) and serves as a
director of Falcon Group and Albion Enterprise VCT. He is also a
member of the advisory boards of 10Sat, Betway Group, ECO Capacity
Exchange and Impala Energy. Lord St John received a BA (Law) and
BSocSc (Psychology) from Cape Town University, BProc (Law) from the
University of South Africa and an LLM from the LSE, London.
Dr. El Sherbini is a professor of clinical pathology at the Faculty of
Medicine, Cairo University and currently sits on the board of American
Society of Clinical Pathology (Egypt) and consults on the international
certification process. She received her MBBCh, Masters in Clinical and
Chemical Pathology, PhD in Immunology from Cairo University, and an
Executive MBA from London Business School. Dr. El Sherbini served as
CEO of Al Mokhtabar since 2004, until becoming CEO of the Group in
2012.
Mr. Choucri is Chairman and Managing Director of HC Securities &
Investment, which he established in May 1996, and he currently sits
on the boards of Edita Food Industries, Six of October Development
and Investment Co. (SODIC), the Holding Company for Tourism, Hotels
& Cinema and the Egyptian British Business Council. Mr. Choucri
served as a Managing Director of Morgan Stanley from 1987 to 1993
and served as Advisory Director at Morgan Stanley from 1993-2007.
He received his Management Diploma from the American University
in Cairo in 1978.
James Patrick Nolan 2,3,4
Independent Non-Executive
Director and Chairman of the
Audit and M&A Committees
Dan Olsson 1,2,3
Independent Non-Executive
Director
Richard Henry Phillips
Non-Executive Director
Mr. Nolan is an Independent Director. He spent 15 years with Royal
Philips NV, latterly as Head of Mergers & Acquisitions, and has also
served as Head of Mergers & Acquisitions at Veon Inc., a major mobile
telecoms operator in Emerging Markets. During his time at Philips, he
led a series of acquisitions in diagnostic imaging, an area in which
Philips is now a global leader. He has extensive quoted-company
board experience having served on the boards of M*Modal Inc.,
Navteq Inc and SHL Telemedicine Ltd.
Mr. Nolan graduated from Oxford University in Law in 1983 and is a qualified
barrister in England and Wales. He also holds an MBA from INSEAD.
Mr. Olsson is CEO of the Team Olivia Group, a Swedish healthcare
group. He has long and extensive international experience in the
diagnostic sector, where he has served in a range of executive
positions, among others as CEO of Unilabs Group in Geneva,
Switzerland from 2007 to 2009 and has worked in the healthcare
sector since 1999. Mr. Olsson studied economics at the University of
Lund in Sweden.
Mr. Phillips is a founding partner of Actis LLP, the emerging markets
private equity group. As Actis LLP is one of the Company's major
shareholders, Mr. Philips is not considered by the Board as being
independent. He established the Actis Global Consumer Sector team
and served as Head of Consumer for four years until becoming a
member of the Actis Investment Committee. During the year he was
responsible for the investment activity of Actis in North Africa and,
latterly, Asia. Mr. Phillips is a director on the board of a number of
companies including Edita Food Industries SAE, Emerging Markets
Knowledge Holdings Ltd. and others. Mr. Phillips holds a degree in
Economics from the University of Exeter.
35
INTEGRATED DIAGNOSTICS HOLDINGSView entire presentation